206 related articles for article (PubMed ID: 21253793)
1. Prostate cancer prevention with 5 alpha-reductase inhibitors.
Parekh DJ
Recent Results Cancer Res; 2011; 188():109-14. PubMed ID: 21253793
[No Abstract] [Full Text] [Related]
2. Guideline supports long-term use of medication to lower prostate cancer risk.
Mitka M
JAMA; 2009 May; 301(17):1753-4. PubMed ID: 19417182
[No Abstract] [Full Text] [Related]
3. Long-Term Effects of Finasteride on Prostate Cancer Mortality.
Goodman PJ; Tangen CM; Darke AK; Lucia MS; Ford LG; Minasian LM; Parnes HL; LeBlanc ML; Thompson IM
N Engl J Med; 2019 Jan; 380(4):393-394. PubMed ID: 30673548
[No Abstract] [Full Text] [Related]
4. The risks and benefits of 5α-reductase inhibitors for prostate-cancer prevention.
Theoret MR; Ning YM; Zhang JJ; Justice R; Keegan P; Pazdur R
N Engl J Med; 2011 Jul; 365(2):97-9. PubMed ID: 21675880
[No Abstract] [Full Text] [Related]
5. The influence of finasteride on the development of prostate cancer.
Thompson IM; Goodman PJ; Tangen CM; Lucia MS; Miller GJ; Ford LG; Lieber MM; Cespedes RD; Atkins JN; Lippman SM; Carlin SM; Ryan A; Szczepanek CM; Crowley JJ; Coltman CA
N Engl J Med; 2003 Jul; 349(3):215-24. PubMed ID: 12824459
[TBL] [Abstract][Full Text] [Related]
6. Few physicians prescribe 5-alpha reductase inhibitors for prostate cancer prevention.
Barton MK
CA Cancer J Clin; 2011; 61(1):1-2. PubMed ID: 21199914
[No Abstract] [Full Text] [Related]
7. Finasteride, a selective 5-alpha-reductase inhibitor, in the prevention and treatment of human prostate cancer.
Reddy GK
Clin Prostate Cancer; 2004 Mar; 2(4):206-8. PubMed ID: 15072601
[No Abstract] [Full Text] [Related]
8. A role for finasteride in the prevention of prostate cancer?
LeFevre M
N Engl J Med; 2013 Aug; 369(7):670-1. PubMed ID: 23944306
[No Abstract] [Full Text] [Related]
9. Finasteride for prostate cancer prevention has no effect on survival, study finds.
McCarthy M
BMJ; 2013 Aug; 347():f5203. PubMed ID: 23963667
[No Abstract] [Full Text] [Related]
10. A big study yields big questions.
Zuger A
N Engl J Med; 2003 Jul; 349(3):213-4. PubMed ID: 12867605
[No Abstract] [Full Text] [Related]
11. Steroid 5 α-reductase inhibitors targeting BPH and prostate cancer.
Schmidt LJ; Tindall DJ
J Steroid Biochem Mol Biol; 2011 May; 125(1-2):32-8. PubMed ID: 20883781
[TBL] [Abstract][Full Text] [Related]
12. Prevention of prostate cancer with finasteride.
Burke HB
N Engl J Med; 2003 Oct; 349(16):1569-72; author reply 1569-72. PubMed ID: 14562806
[No Abstract] [Full Text] [Related]
13. Finasteride for prevention of prostate cancer.
Med Lett Drugs Ther; 2008 Jun; 50(1289):49-50. PubMed ID: 18583946
[No Abstract] [Full Text] [Related]
14. [The Prostate Cancer Prevention Trial (PCPT). Relevance for clinical practice].
Schmitz-Dräger BJ; Fischer C; Bismarck E; Dörsam HJ; Lümmen G
Urologe A; 2007 Oct; 46(10):1364, 1366-8, 1370. PubMed ID: 17874228
[TBL] [Abstract][Full Text] [Related]
15. Role of 5α-reductase inhibitors in prostate cancer prevention and treatment.
Azzouni F; Mohler J
Urology; 2012 Jun; 79(6):1197-205. PubMed ID: 22446342
[TBL] [Abstract][Full Text] [Related]
16. Survival in the prostate cancer prevention trial.
Revannasiddaiah S; Susheela SP
N Engl J Med; 2013 Nov; 369(20):1967. PubMed ID: 24224634
[No Abstract] [Full Text] [Related]
17. Survival in the prostate cancer prevention trial.
Walsh PC
N Engl J Med; 2013 Nov; 369(20):1967. PubMed ID: 24224633
[No Abstract] [Full Text] [Related]
18. The use of the finasteride-adjusted Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator in a Mexican referral population: a validation study.
Liang Y; Ketchum NS; Louden C; Jimenez-Rios MA; Thompson IM; Camarena-Reynoso HR
Urol Int; 2012; 89(1):9-16. PubMed ID: 22626812
[TBL] [Abstract][Full Text] [Related]
19. The utility of 5-alpha reductase inhibitors in the prevention and diagnosis of prostate cancer.
Reed AB; Parekh DJ
Curr Opin Urol; 2009 May; 19(3):238-42. PubMed ID: 19318950
[TBL] [Abstract][Full Text] [Related]
20. The evolution of the PCPT from clinical to molecular analyses.
Hoque A
Nat Clin Pract Oncol; 2006 Nov; 3(11):581. PubMed ID: 17080169
[No Abstract] [Full Text] [Related]
[Next] [New Search]
